Page 555 - Enfeksiyon Hastalıkları Kitabı

Kaynaklar 535

İdrar Yolları. In: İnfeksiyon Hastalıklarında Klinik Problemler El blind, randomized, controlled trial. Ann Intern Med.
Kitabı. (Yazarlar; Gantz NM, Brown RB, Berk SL). 4. Baskı. 1997;126: 697-703.
Güneş Kitabevi, Ankara; 2001.
Kılıçturgay, K. Leptospiroz. In: İç Hastalıkları. (Yazarlar; Öbek
İnan D. İzolasyon önlemleri. http://www.rshm.gov.tr/enfeksi- A). 4. baskı. Güneş Kitabevi; Bursa; 1990.
yon/dosya/izolasyon.pdf Erişim tarihi: 04.01.2013.
Klein JD. Mumps. In: Conn’s Current Therapy 2011. (Eds; Bope ET.

Jaffe WA, Schroeter AL, Reynolds GH, Zaidi AA, Martin Jr. , JE, Kellerman R. Rakel RE). Elsevier-Saun ders, Philadelphia; 2011.

Thayer JD. Pharmacokinetic Determinants of Penicillin Cure Kneen R, Pham NG, Solomon T, et al. Penicillin vs. erythromy-

of Gonococcal Urethritis. Antimicrob Agents Chemother. cin in the treatment of diphtheria. Clin Infect Dis 1998;
1979 April; 15(4): 587-591.
27(4):845-850.
John DT, Petri WA, Jr (eds). Markell and Voge’s Medical Parasi- Knobel B, Rudman M, Smetana S.Acute renal failure as a comp-
tology. (Edes; John DT, Petri WA, Jr). 9th edition. Saunders lication of cholera. Harefuah 1995;129:552-555.
Elsevier, St. Louis, Missouri; 2006.
Kohanski MA, Dwyer DJ, Hayete B, et al. A common mecha-
Johnson MT, Reichley R, Hoppe-Bauer J, et al. Impact of previ- nism of cellular death induced by bactericidal antibiotics.
ous antibiotic therapy on outcome of Gram-negative severe Cell 2007;130:797-810.
sepsis. Crit Care Med 2011; 39:1859.
Korkmaz M.: Bağırsak Helmintleri ANKEM Derg 2006;20 (Ek
Jones RN, Jenkins SG, Hoban DJ, et al. In vitro activity of selec- 2): 170-176.
ted cephalosporins and erytromycin against staphylococci
and pneumococci isolated at 38 North American Medical Kosek M, Yori PP, Olortegui MP. Shigellosis update: advancing
Centers participating in the SENTRY, Antimicrobial Surve- antibiotic resistance, investment empowered vaccine deve-
illance Programm, 1997-1998. Diagn Microbial Infect Dis lopment, and green bananas. Curr Opin Infect Dis 2010; 23:
2000; 37: 93-98. 475-480.
Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on Kotton CN, Kumar D, Caliendo AM, et al. International consen-
hantavirüs ecology, epidemiology, and disease. Clin Micro- sus guidelines on the management of cytomegalovirus in so-
biol Rev. 2010; 23(2): 412-441. lid organ transplantation. Transplantation 2010;89:779-795.
Jonsson IM, Pietrocola G, Speziale P, et al. Role of fi brinogen- Köksal İ (Çeviren), Yao JDC, Moellering RC. Antibakteriyel Ajan-
binding adhesin expression in septic arthritis and septi- lar. Başustaoğlu A. (Çeviri Editörü), Murray PR. Klinik Mik-
cemia caused by Streptococcus agalactiae. J Infect Dis. robiyoloji Kitabı, 9. Baskı, Atlas Kitapçılık, 2010, 1077-1112.
2005;192(8):1456-1464.
Köse Ş, Ersan G, Akkoçlu G, Gözaydın A, Ulu Y. Transaminaz
Jorge LS, Chueire AG and Rossit ARB.Osteomyelitis: a current Enzim Yüksekliği Olan Olgulara Sistematik Yaklaşım. Viral
challenge.Braz J Infect Dis 2010;14:310-315 Hepatit Derg 2011; 17(2): 41-46.
Kallio-Kokko H, Uzcategui N, Vapalahti O, Vaheri A. Viral zoo- Krishna BV, Patil AB, Chandrasekhar MR. Fluoroquinolone-re-
noses in Europe. FEMS Microbiol Rev. 2005;29(5):1051-77. sistant Vibrio cholerae isolated during a cholera outbreak in
India. Trans R Soc Trop Med Hyg. 2006;100:224–226.
Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet
J, Dalton HR. Hepatitis E. Lancet 2012;379:2477-2488. Kullberg BJ, Sobel JD, Ruhnke M, et al: Voriconazole versus a

regimen of amphotericin B followed by fluconazole for Can-
Kamath S. Fever in General Practice. Quarterly Medical Revi- didaemia in non-neutropenic patients: a randomised non-
ew. 2008;59(2):1-38 http://www.raptakos.com/QMR_Apr_ inferiority trial. Lancet 2005;366:1435-1442.
Jun_2008.pdf
Küçükbasmacı Ö. Ketolid grubu ilk antibiyotik: Telitromisin.
Kara A, Özkaya ParlakayA, Gü r D ve ark. Grup A Beta Hemo- Tü rk Mikrobiyol Cem Derg 2008;38 (3-4):156-561
litik Streptokok Tü rkiye Makrolid Direnç Değerlendirmesi

Pilot Çalışma Sonuçları. J Pediatr Inf 2011;5:96-99. Labelle A, Juang P, Reichley R, et al. The determinants of hospital
mortality among patients with septic shock receiving app-
Karabay O, Özdemir D, Güçlü E ve ark. Aile Hekimlerinin An- ropriate initial antibiotic treatment*. Crit Care Med 2012;
tibiyotik Kullanımı Konusundaki Tutumları. J Microbiol In- 40:2016.
fect Dis. 2011; 1: 53-57.
Laferriere CI, Marks MI. Chloramphenicol: properties and clini-
Karakaş, A., Turhan, V. 2010. Leptospiroz; “Tufan sonrası hum- cal use. Pediatr Infect Dis 1982: 6; 257-264.
ma”. (“Leptospirosis; Fever Aftermath of Deluge”). TAF Prev
Med Bull. 9(6): 651-654. Lagoy CT, Joshi N, Cragan JD, Rasmussen SA. Medication use
during pregnancy and lactation: an urgent call for public he-
Kart Yaşar K., F.Pehlivanoğlu, Şengöz G. Alternatif tedavi se- alth action.J Womens Health (Larchmt). 2005;14(2):104-9.
çeneği olarak fosfomisinin ürine sitem enfeksiyonlarından
izole edilen ESBL pozitif E. coli suşlarına etkinliği ANKEM LaRocque R, Pietroni M. Approach to the adult with acute di-
Derg 2011;25(1):12-16. arrhea in developing countries, 2013 UpToDate, Inc.( http://
www.uptodate.com/contents/approach-to-the-adult-with-
Katti MK. Pathogenesis, diagnosis, tretment, and outcome as- acute-diarrhea-in-developing-countries?source= search_
pects of cerebral tuberculosis. Med Sci Monit 2004;10:215- result&search=acute+ diarrhea&selected Title=2%7E94
229. (erişim tarihi: 7 Ocak 2013)
Keddy KH, Sooka A, Crowther-Gibson P, et al. Systemic shigel- Leblebicioğlu H. Güncel Rehberler Işığında Kronik Hepatit B’de
losis in South Africa. Clin Infect Dis 2012; 54: 1448. Tedavi. Flora 2010;15 (Ek 2):10-18.
Khan WA, Seas C, Dhar U, et al. Treatment of shigellosis: V. Leblebicioğlu H. Makrolidler. www. oocities. org/hakanomu/

Comparison of azithromycin and ciprofloxacin: A double- makrolidler. pdf